Repatha 140 MG/ML sureclickml
Ended Awarded Last action
- Contract number
- SPE2DR26F73AE
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,915
Award facts
- Contract value 100% obligated
- $11,915.15 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a $11,915.15 delivery order (Contract No. 4570268783) to AmerisourceBergen Drug Corp on December 12, 2025, for the supply of Repatha 140 mg/ml SureClick auto-injectors. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of December 15, 2025, and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. Repatha is a PCSK9 inhibitor used to treat high cholesterol in patients at risk for cardiovascular disease, representing a specialized pharmaceutical product within DLA's medical supply portfolio.
This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This comprehensive prime vendor contract enables AmerisourceBergen to supply an extensive range of pharmaceutical products and medical supplies—including specialty medications, brand-name and generic drugs, vaccines, and medical devices—to support military healthcare systems globally. As a major pharmaceutical distributor and critical federal vendor, AmerisourceBergen has consistently won competitively awarded contracts with DLA to support Defense Health Agency, U.S. Coast Guard, and other government healthcare system requirements.
Quick answers
Who was awarded contract SPE2DR26F73AE?
SPE2DR26F73AE was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 12, 2025.
How much is contract SPE2DR26F73AE worth?
The government has obligated $11,915 on SPE2DR26F73AE.
Is contract SPE2DR26F73AE an order under another contract?
Yes. SPE2DR26F73AE is a delivery order under SPE2DR25D1202, an indefinite delivery contract.
Was contract SPE2DR26F73AE competed?
The extent of competition for SPE2DR26F73AE was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award